Cas No.: 1926163-30-5
PRODUCT INFORMATION
Description
This tumor-targeted pro-apoptotic peptide, CNGRC-GG-D(KLAKLAK)₂, integrates a tumor-homing CNGRC domain (targeting CD13) and a cytotoxic (KLAKLAK)₂ module. The (KLAKLAK)₂ moiety destabilizes mitochondrial membranes to induce caspase-dependent apoptosis in target cell lines. Its disulfide-bridged architecture enhances accumulation in research models, demonstrating potent in vitro cytotoxic activity.
Molecular Weight
2168.72
Purity
> 95%
Formula
C₉₄H₁₇₄N₃₂O₂₂S₂
Product Type
Targeting Peptide
Sequence
Cys-Asn-Gly-Arg-Cys-Gly-Gly-Lys-Leu-Ala-Lys-Leu-Ala-Lys-Lys-Leu-Ala-Lys-Leu-Ala-Lys-NH₂ (Disulfide bridge:Cys1-Cys5)
Form (20 deg.C)
Solid
Storage Condition
Store the product under the recommended conditions in the Certificate of Analysis (CoA).
For Research Use Only | Not For Clinical Use
Related products
- NGR Peptide TFA (CAT#: OLY-1025-YS-59)
- CXCL8 (54-72) Targeting Peptide (CAT#: OLY-1025-YS-1)
- IETP2 Targeting Peptide (CAT#: OLY-1025-YS-30)
- Cyclo(Arg-Gly-Asp-D-Phe-Glu) Targeting Peptide (CAT#: OLY-1025-YS-64)
- T9 Targeting Peptide (CAT#: OLY-1025-YS-19)
- GPC3 Targeting Peptide 1 (CAT#: OLY-1025-YS-37)
- CREKA Targeting Peptide (CAT#: OLY-1025-YS-18)
- WLSEAGPVVTVRALRGTGSW TFA Targeting Peptide (CAT#: OLY-1025-YS-67)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.